Form 4: Nuvalent Director Matthew Shair Executes Stock Sales Under 10b5-1 Plan

Matthew Shair, a director at Nuvalent, Inc., sold shares of Class A Common Stock on May 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 13, 2024, Matthew Shair, a director of Nuvalent, Inc., executed multiple sales of Class A Common Stock.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• A total of 37,490 shares were sold at weighted average prices ranging from $65.42 to $66.86.
• Following these transactions, Shair directly owns 1,424,698 shares of Class A Common Stock.
• Additionally, 236,522 shares are held indirectly through the Matthew D. Shair 2021 Irrevocable Family Trust, over which Shair has voting and dispositive power.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged trading plan, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of insider trading. The market typically views these sales in the context of the overall trading volume and the individual's holdings.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders if they interpret the sales negatively, although the existence of a 10b5-1 plan mitigates this concern.
• The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates